Alternate brands of REVOLADE -

Revolade 50Mg 25Mg 75Mg Eltrombopag Olamine Tablets Novartis revolade Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments revolade Revolade 50mg Tablet contains the active constituent eltrombopag It is used to treat low platelet counts caused by immune primary thrombocytopenia or

revolade Revolade Tablet contains Eltrombopag, a thrombopoietin receptor agonist used to treat low blood platelet counts Megakaryocytes, large bone